InvestorsHub Logo
icon url

jomama9231

06/05/21 9:41 PM

#342371 RE: iryokabu #342370

I thought the epa blood levels in strength never reached the height of those in reduce it so it could still be the epa blood level that is meaningful. Higher being better. Obviously dha mattering too in strength.
icon url

Whalatane

06/05/21 9:43 PM

#342372 RE: iryokabu #342370

Thx
Kiwi
icon url

Chemist2

06/06/21 12:34 AM

#342378 RE: iryokabu #342370

Hi iryokabu; I held up my "EPA/AA?" sign at the FDA meeting in 2019 and asked Dr. Bhatt that day as well. His answer was essentially, we'll see. Who knows if the data is in the Reduce-it database to evaluate these two ratios(EPA/AA & EPA/DHA)?
icon url

sts66

06/07/21 5:38 PM

#342575 RE: iryokabu #342370

We don't know what the EPA/AA ratio was in STRENGTH, so why dismiss it as being a factor? And median EPA levels were nearly half that of patients in R-IT, so at best EPA/AA would be half as good as R-IT. Do we even know EPA/AA for R-IT?